Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare
Details : Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.
Product Name : CSbioactive
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 07, 2021
Lead Product(s) : Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract ...
Product Name : Collavant n2
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
July 09, 2020
Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Bioiberica
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.
Product Name : Condrovet
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
September 06, 2020
Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Bioiberica
Deal Size : Undisclosed
Deal Type : Agreement